Please use this identifier to cite or link to this item:
Title: Evaluation of 2 trilostane protocols for the treatment of canine pituitary-dependent hyperadrenocorticism: Twice daily versus once daily
Authors: Arenas, C.
Melián Limiñana, Carlos 
Pérez-Alenza, M. D.
UNESCO Clasification: 310907 Patología
Keywords: Cushing's
Internal medicine
Issue Date: 2013
Publisher: 0891-6640
Journal: Journal of Veterinary Internal Medicine 
Abstract: Trilostane is the drug of choice to treat pituitary-dependent hyperadrenocorticism (PDH) in dogs, but there is still controversy about which protocol best controls the clinical signs and results of adrenal functioning test.
ISSN: 0891-6640
DOI: 10.1111/jvim.12207
Source: Journal of Veterinary Internal Medicine [ISSN 0891-6640], v. 27, p. 1478-1485
Appears in Collections:Artículos
Show full item record

Google ScholarTM




Export metadata

Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.